71616;Drug Synergism;Depression
83942;Time Factors;Half-Life;Biological Availability
85186;Drug Synergism;Pakistan;England;Phytotherapy
85872;Absorption;Depression, Chemical;Gastric Emptying
214657;Time Factors;Prostaglandins E;Blood Platelets
314074;Drug Interactions
323461;Time Factors;Half-Life;Biological Availability;Kinetics
363052;Kinetics
406701;Drug Interactions;Amine Oxidase (Copper-Containing)
427007;Time Factors;Biological Availability;Kinetics
438273;Hallux
445958;Time Factors;Patient Compliance
463881;Drug Interactions
496127;Drug Interactions
501875;Wisconsin
512843;Half-Life;Biological Availability;Kinetics
520399;Time Factors;Biological Availability;Kinetics;Propanolamines
558210;Aldehyde Oxidoreductases;Cyclopropanes;Glutamine
564228;Drug Interactions
569766
571023
581516;Biological Availability;Saliva;Tears
589392
637437
647881;Drug Interactions;Time Factors;Biological Availability
665675;Biological Availability
758247;Biological Availability
780287;Kinetics
838114
872490;Time Factors;Biological Availability;Kinetics
872491;Time Factors;Biological Availability;Kinetics;Propanolamines
970990;Time Factors;Biological Availability
991535;Half-Life
1036443;Drug Synergism;Postural Balance
1167931;Terminology as Topic;Folklore;Nigeria
1195132;Analgesia;Brain;Drug Interactions;Hydroxydopamines;Drug Tolerance
1215448;Mental Processes;Lactates;Automobile Driving;Motor Skills;Postural Balance
1241098;Chemical Phenomena;Aldehyde Oxidoreductases;Acetaldehyde;Glutamine
1297641;Absorption;Half-Life;Biological Availability
1335461
1351673;Psychomotor Performance
1404208
1424410;Drug Synergism
1468429;Drug Interactions
1476449;Enterotoxins;Staphylococcus aureus
1483487;Drug Synergism;Benzamides
1577050
1605619;Biological Availability
1612815;Biological Availability;South Africa
1621740;Age Factors;Biological Availability
1656742;Drug Interactions;Age Factors;Contraindications
1662623;Tissue Distribution;Drug Interactions;Time Factors;Half-Life;Biological Availability
1672944;Drug Interactions;Biological Availability
1672990;Pregnancy
1679514;Drug Interactions
1681621;Chemistry, Pharmaceutical
1683458
1706804;Biological Availability
1748529
1752235;Drug Interactions
1766062
1772462;Biological Availability
1774159;Drug Therapy, Combination
1780961;Drug Interactions;Biological Availability
1781863
1797525;Dose-Response Relationship, Drug;Receptors, Dopamine;Appetitive Behavior;Association Learning;Discrimination Learning
1912131;Drug Interactions
1914371;Dose-Response Relationship, Drug;Drug Interactions;Time Factors;Catecholamines;Natriuresis
1914375;Drug Interactions;Stereoisomerism;Metabolism
1934862;Biological Availability
1934866;Dose-Response Relationship, Drug
1956499;Drug Interactions
1981783;Drug Interactions;Half-Life
1988422;Drug Interactions;Hong Kong
2042654;Drug Synergism;Time Factors;Contraindications
2045759;Clinical Protocols;Drug Resistance
2049250;Gastric Emptying
2051716;Tissue Distribution
2058471;Kinetics
2065699;Acetaldehyde
2065700;Acetaldehyde
2066050;Time Factors;Drug Tolerance
2069371;Drug Interactions;Half-Life
2071262
2091623;Dose-Response Relationship, Drug;Drug Interactions;Glutamates
2099431;Drug Interactions;Heart Valve Prosthesis;Aortic Valve
2106407;Drug Interactions;Drug Resistance
2107985;Heart
2112643;Amino Acids
2114955;Absorption;Biological Availability
2122025;Biological Availability;Polyurethanes;Hydrogen-Ion Concentration
2122422;Time Factors;Biological Availability
2171446;Drug Synergism
2177401;Drug Interactions
2200264;Drug Interactions;Stereoisomerism
2253583;Drug Interactions
2271748;Biological Availability
2285293;Absorption;Time Factors
2311339;Biological Availability
2338118;Biological Availability
2352608
2353062
2357862;Drug Synergism;Drug Interactions;Sympathetic Nervous System;Affect
2360879
2396245;Drug Therapy;Drug Residues
2450251;Drug Synergism;Absorption;Benzamides
2492043;Drug Interactions
2496251;Drug Resistance
2501937
2506806;Biological Availability
2510372
2527534;Biological Availability
2565585;Fatty Acids, Essential;Linoleic Acids;gamma-Linolenic Acid
2580171;Half-Life;Proline;Protein Binding;Kinetics
2580172;Renin;Time Factors;Proline;Peptidyl-Dipeptidase A
2589383;Drug Synergism;Bacteria;Drug Therapy, Combination
2612087;Drug Synergism;Urodynamics;Biological Availability
2613389;Biological Availability;Gallbladder
2663579
2666453
2673623;Dose-Response Relationship, Drug;Drug Synergism;Pressoreceptors;Benzamides
2686430;Drug Interactions
2714732;Drug Interactions;Benzamides
2729942;Drug Interactions;Half-Life
2735334
2764304;Anesthesia, General;Anesthesia, Epidural;Consciousness
2767766;Absorption;Biological Availability
2794993;Drug Synergism;Time Factors;Benzamides
2795213;Heart
2821081;Biological Availability
2875358
2876719;Critical Care;Kinetics;Respiration, Artificial
2880045
2901653
2913801;Drug Interactions;Renal Dialysis
2914409;Drug Interactions;Age Factors
2929629;Drug Interactions
2938522
2985676;Drug Interactions;Biological Availability;Kinetics
3014110;Time Factors;Biological Availability
3038451;Absorption;Biological Availability;Kinetics
3038494;Drug Interactions;Biological Availability
3040815;Kinetics
3053579;Drug Interactions
3085485
3100311
3110450;Drug Resistance
3116961
3121288;Drug Interactions;Time Factors;Biological Availability
3127188
3189445;Menopause;Cosmetics
3220610
3228106;Solvents;Time Factors
3243931;Half-Life
3259827;Heart
3278460;Absorption;Drug Interactions
3283290;Drug Synergism;Benzamides;Phenethylamines
3338980
3356120;Biological Availability;Gastric Acid
3366169
3372933
3389610;Drug Interactions
3392235;Time Factors;Half-Life
3414579;Pregnancy;Maternal-Fetal Exchange;Gestational Age;Hemoglobins
3460737;Kinetics
3475034;Kinetics
3480885;Drug Interactions;Half-Life
3481318;Drug Interactions
3499163;Biological Availability
3517081;Learning;Drug Interactions;Memory;Drug Tolerance;Cognition;Psychological Tests;Kinetics;Emotions
3525654;Patient Education as Topic
3541503;Drug Interactions
3565796;Psychomotor Performance;Time Factors;Anesthesia, Intravenous;Anesthesia, Spinal
3665325
3682151
3693341;Drug Interactions
3693584
3720177;Absorption;Biological Availability;Kinetics
3734141;Psychomotor Performance;Drug Interactions;Evoked Potentials;Kinetics
3778707;Renal Dialysis
3790404;Absorption;Biological Availability;Kinetics
3807390;Sri Lanka
3824426
3838321;Time Factors
3838971;Drug Interactions
3877043;Drug Interactions;Enzyme Induction;Microsomes, Liver;Cytochrome P-450 Enzyme System
3910768
3948402;Hydrogen-Ion Concentration
3988971;Drug Interactions;Dipeptides
3998202;Drug Interactions
3998343;Drug Interactions
4000229;Drug Synergism;Ethanolamines
4003328;Israel;Erythrocytes, Abnormal;Hemoglobins;Social Class
4005122;Kinetics
4006379;Absorption;Biological Availability;Kinetics;Hydrogen-Ion Concentration
4014747;Wakefulness
4029248;Drug Interactions;Cytochrome P-450 Enzyme System
4042520;Absorption;Drug Interactions;Smoking
4064930;Kinetics
4099618;Mouth Mucosa;Hydrogen-Ion Concentration
4909796;Drug Synergism;Behavior Therapy;Depression
4964450;Protein Binding
4967225
5104893;Drug Synergism
5132558;Brain;Drug Interactions
5304704
5676383;Diuresis;Urea;Kidney
5897315;Absorption
5948152
6034391
6091711;Biological Availability;Gastric Acid
6097665;Dipeptides;Biological Availability
6112560;Drug Antagonism
6113376;Kidney
6116064
6124334;Mental Processes;Drug Interactions;Motor Skills
6129542;Drug Antagonism
6130074;Psychomotor Performance;Drug Interactions;Motor Skills
6133016;Drug Synergism;Magnoliopsida
6142202;Receptors, Cell Surface;Receptors, GABA-A
6149298;Tannins;Drug Interactions;Gallic Acid;Chemical Phenomena;Hydrolyzable Tannins;Hydrogen-Ion Concentration
6236021;Drug Synergism;Kidney;Leg
6242951;Homeostasis
6282000;Biological Availability
6285814;Kinetics
6322675;Half-Life;Kinetics
6327318;Kinetics;Hydrogen-Ion Concentration
6374311;Dose-Response Relationship, Drug;Psychomotor Performance;Drug Antagonism;Cognition
6389377;Drug Interactions;Proline;Biological Availability;Kinetics
6394124
6419147;Absorption
6421377
6437219;Drug Interactions
6438282;Time Factors
6486489;Arousal
6486994;Heart Valve Prosthesis;Drug Resistance
6522416;Reinforcement (Psychology)
6612697;Drug Interactions;Biotransformation;Biological Availability;Kinetics
6614033;Urea
6626418
6662173;Psychomotor Performance;Anxiety;Kinetics
6678751;Kinetics;Hydrogen-Ion Concentration
6688049;Half-Life;Kinetics
6688407;Butanones;Drug Interactions;Sex Factors;Biological Availability
6692645;Kinetics
6723218
6734044;Phenotype
6734698;Half-Life;Kinetics
6741669;Menstruation;Discrimination (Psychology);Drug Tolerance;Set (Psychology)
6786635
6794970;Absorption;Biological Availability
6803191
6806502
6807440
6821036
6834589
6843604
6882312;Drug Synergism;Drug Interactions;Memory
6883912;Cooking;Half-Life
6926836;Biological Availability
6956293;Absorption;Biological Availability
7040498;Time Factors;Biotransformation;Proline;Biological Availability;Feces
7053307;Drug Interactions;Kinetics;Motor Skills;Emotions
7076627;Drug Interactions
7098543;Dose-Response Relationship, Drug;Mental Processes;Muscle Contraction;Muscle Relaxation;Temperament
7104169;Half-Life;Biological Availability;Kinetics;Ethanolamines
7105982;Drug Interactions
7118763;Time Factors;Biological Availability;Kinetics
7174567;Biological Availability
7188722;Drug Interactions
7197483
7197984;Drug Interactions
7212893;Drug Resistance
7237895;Biological Availability;Kinetics
7270565;Drug Interactions;Drug Resistance
7274023;Drug Interactions;Drug Resistance
7308273;Biological Availability;Saliva
7312071;Netherlands;Drug Resistance
7343191;Menstruation
7359014;Absorption;Menstruation;Time Factors;Sex Factors;Half-Life;Kinetics;Binding Sites
7371698;Drug Interactions;Time Factors;Biotransformation;Half-Life;Kinetics;Ethanolamines
7383081;Drug Resistance
7406391
7454487;Biodegradation, Environmental;Half-Life;Individuality;Kinetics;Microsomes, Liver
7486898;Gastric Acid;Hydrogen-Ion Concentration
7551902
7582380;Dose-Response Relationship, Drug;Absorption;Biotransformation;Food-Drug Interactions;Half-Life;Cytochrome P-450 CYP1A2;Oxidoreductases;Cytochrome P-450 Enzyme System
7589032;Time Factors;Kinetics
7619679;Mixed Function Oxygenases;Cytochrome P-450 CYP3A
7628179;Food-Drug Interactions;Biological Availability
7640830;Emergency Service, Hospital;Drug Interactions;Time Factors
7648762;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Sleep Stages;Food-Drug Interactions;Biological Availability
7677856;Absorption;Cytochrome P-450 Enzyme System
7697949;Food-Drug Interactions
7715468;Estrogen Replacement Therapy;Drug Interactions;Biotransformation;Biological Availability
7742162;Food-Drug Interactions
7748990;Dose-Response Relationship, Drug;Personality Inventory
7768070;Biological Availability
7811026;Biological Availability
7856583
7859239;Food-Drug Interactions;Half-Life;Biological Availability;Therapeutic Equivalency
7875189;Urine;Biological Availability
7881701;Drug Interactions;Time Factors;Drug Therapy, Combination
7955811;Absorption;Biological Availability
7962690;Dose-Response Relationship, Drug;Drug Therapy, Combination;Schizophrenic Psychology
7967987;Activities of Daily Living;Benzamides;Drug Therapy, Combination
7972311;Biotransformation;Food-Drug Interactions;Biological Availability
7979646;Drug Synergism;Time Factors;Sudan
7990219;Drug Synergism
8004359;Drug Interactions;Half-Life;Biological Availability
8039534;Time Factors
8049637;Inactivation, Metabolic;Carcinogens;Half-Life;Allyl Compounds
8061850;Dose-Response Relationship, Drug;Drug Interactions;Age Factors
8064267
8073064;Half-Life;Biological Availability
8148213;Sincalide
8200332;Absorption;Drug Interactions
8218972;Biological Availability;Mexico
8275614;Drug Interactions
8364261
8365689;Drug Interactions;Combined Modality Therapy
8388198;Biological Availability
8390020
8391300;Drug Interactions;Neural Conduction;Leg
8395986;Cross Reactions;Sodium-Potassium-Exchanging ATPase;Magnoliopsida
8453178
8513655;Drug Interactions;Biological Availability
8521677;Drug Interactions;Age Factors;Sex Characteristics
8527268;Half-Life;Biological Availability
8540731;Protein Binding;Biological Availability
8549357;Food-Drug Interactions
8549360
8554942;Psychomotor Performance;Drug Interactions;Evoked Potentials, Visual
8562295;Food-Drug Interactions
8601555;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP1A2;Oxidoreductases;Cytochrome P-450 CYP2D6;Cytochrome P-450 Enzyme System
8602393;Drug Interactions
8607732;Drug Synergism;Tongue
8612381;Time Factors;Heart Conduction System;Biological Availability
8617704;Food-Drug Interactions
8631189;Time Factors;Menstrual Cycle;Biological Availability;Estradiol Congeners;Cytochrome P-450 Enzyme System
8642453;Bone and Bones;Biological Availability
8649594
8689808;Drug Interactions;Cytochrome P-450 Enzyme System
8693526;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Biological Availability;Cytochrome P-450 Enzyme System
8728348;Phenotype;Food-Drug Interactions;Biological Availability
8735685
8739026
8751023;Time Factors
8787869;Biological Availability
8813897;Biological Availability
8830073;Dose-Response Relationship, Drug;Drug Synergism;Cytochrome P-450 CYP1A2;Oxidoreductases
8851570;Food-Drug Interactions;Biological Availability
8866042;Food-Drug Interactions;Biological Availability
8869767;Drug Synergism
8881693;PUVA Therapy;Food-Drug Interactions
8911887
8925804;Amines;Cyclohexanecarboxylic Acids;Acetates
8926537;Energy Metabolism;Carbohydrate Metabolism;Oxygen Consumption;Running;Lipid Peroxidation
8929750;Stomach;Drug Interactions;Half-Life;Biological Availability;Gastric Acid;Hydrogen-Ion Concentration
8947977;Food-Drug Interactions
8961058
8971132;Methylene Chloride;Cytochrome P-450 CYP3A;Oxidoreductases, N-Demethylating;Aryl Hydrocarbon Hydroxylases;Microsomes, Liver
8988067;Food-Drug Interactions;Isothiocyanates
9002010;Dose-Response Relationship, Drug;Drug Interactions
9075501;Food-Drug Interactions
9091822
9114910;Absorption
9129557;Food-Drug Interactions
9147710;Food-Drug Interactions;Half-Life
9153347;Stereoisomerism;Postprandial Period
9159606;Drug Synergism
9174684;Tissue Distribution;Intestines;Drug Interactions
9217843;PUVA Therapy;Magnoliopsida
9218932;Time Factors;Hydrogen-Ion Concentration
9220063;Food-Drug Interactions
9234037;Dose-Response Relationship, Drug;Psychomotor Performance;Psychiatric Status Rating Scales;Drug Interactions;Time Factors;Self-Assessment;Behavior;Affect
9248771;Biological Availability
9315022;Complementary Therapies;Drug Interactions;Phytotherapy
9357093;Food-Drug Interactions;Half-Life;Biological Availability
9385040;Drug Interactions;Time Factors;Half-Life
9399621;Drug Interactions;Drug Resistance
9414309;Drug Synergism;Biological Availability
9431825
9469677;Food-Drug Interactions
9518947;Drug Synergism;Central Nervous System
9545149;Dose-Response Relationship, Drug;Food-Drug Interactions;Biological Availability
9555149;Food-Drug Interactions
9562133;Amines;Food-Drug Interactions;Cyclohexanecarboxylic Acids;Acetates
9562227;Food-Drug Interactions;Biological Availability
9566982;Nutrition Policy
9578182;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Food-Drug Interactions;Half-Life;Biological Availability;Cytochrome P-450 Enzyme System
9585793;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Food-Drug Interactions;Cytochrome P-450 Enzyme System
9591935;Dose-Response Relationship, Drug;Drug Synergism
9604823;Serum Albumin;Time Factors;Clinical Nursing Research
9609412;Biological Availability;Critical Care
9620100;Time Factors;Bromobenzenes;Food-Drug Interactions;Benzophenones;Biological Availability
9620116;Food-Drug Interactions;Biological Availability
9625273;Biological Availability;Cytochrome P-450 Enzyme System
9633781
9660036;Half-Life
9696960;Food-Drug Interactions
9706183;Food-Drug Interactions
9738088;Drug Contamination
9757152;Time Factors;Food-Drug Interactions
9768962;Drug Interactions
9793589;Postprandial Period;Biological Availability
9793622;Food-Drug Interactions;Biological Availability
9800751
9807978;Biological Availability
9818297;Food-Drug Interactions
9834039;Food-Drug Interactions
9840238;Time Factors;Biological Availability
9871430;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Food-Drug Interactions;Half-Life;Cytochrome P-450 Enzyme System
9882081;Drug Interactions;Food-Drug Interactions;Biological Availability
9924842;Drug Interactions;Herb-Drug Interactions;Brazil
10030529;Drug Interactions;Phytotherapy;Patient Education as Topic
10073324;Drug Interactions;Cyclohexanols;Time Factors;Cytochrome P-450 CYP1A2
10082701;Drug Interactions
10086430;Drug Interactions
10096255;Mixed Function Oxygenases;Intestinal Mucosa;Cytochrome P-450 CYP3A;Food-Drug Interactions;ATP-Binding Cassette, Sub-Family B, Member 1;Cytochrome P-450 Enzyme System
10096258;Drug Interactions;Cytochrome P-450 CYP1A2;Microsomes, Liver
10102468;Drug Interactions;Drug Tolerance
10192596;Food-Drug Interactions
10217316;Drug Interactions
10220126;Psychiatric Status Rating Scales;Food-Drug Interactions;Schizophrenic Psychology
10243361;Hospital Bed Capacity, 500 and over;Social Environment;Nebraska
10332534
10350016;Hydrogen-Ion Concentration
10365642;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Biological Availability;Cytochrome P-450 Enzyme System;Hydrogen-Ion Concentration
10375176;Drug Interactions;Medicine, Chinese Traditional;Herb-Drug Interactions;Protein Binding;Phytotherapy
10423213;Food-Drug Interactions
10440622;Food-Drug Interactions;Biological Availability
10456490;Drug Interactions
10456492;Heart;Drug Interactions;Sesquiterpenes;Biological Availability;Saliva
10460065;Half-Life;Heptanoic Acids
10460103;Drug Interactions;Food-Drug Interactions;Biological Availability
10471985;Estrogen Replacement Therapy;Drug Interactions;Menopause;Cytochrome P-450 CYP1A2
10510161;Drug Interactions
10533874;Drug Interactions;Herb-Drug Interactions;Phytotherapy
10546917;Time Factors;Phytotherapy
10546919;Food-Drug Interactions
10546925;Time Factors;Food-Drug Interactions;Sesquiterpenes;Biological Availability
10556183;Age Factors
10568341;Drug Interactions
10578942;Anxiety;Phytotherapy
10583025;Caco-2 Cells;Mixed Function Oxygenases;Drug Interactions;Time Factors;Cytochrome P-450 CYP3A;ATP-Binding Cassette, Sub-Family B, Member 1;Cytochrome P-450 Enzyme System
10594487;Cytochrome P-450 CYP2C9;Mixed Function Oxygenases;Drug Interactions;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP2E1;Cytochrome P-450 CYP1A2;Steroid 16-alpha-Hydroxylase;Aryl Hydrocarbon Hydroxylases;Steroid Hydroxylases;Cytochrome P-450 Enzyme System
10606838;Biotransformation
10610011;Food-Drug Interactions
10615351
10636361;Drug Interactions
10638471;Time Factors
10681341;Plasmodium falciparum;Food-Drug Interactions;Sesquiterpenes;Biological Availability;Drug Therapy, Combination;Ethanolamines
10683008;Drug Interactions;Graft Rejection
10702883;Biological Availability
10706847
10740993;Food-Drug Interactions
10741622;Mixed Function Oxygenases;Time Factors;Cytochrome P-450 CYP3A;Food-Drug Interactions;Cytochrome P-450 Enzyme System
10759694;Cytochrome P-450 CYP3A;Biotransformation;Food-Drug Interactions;Half-Life;Oxidoreductases, N-Demethylating;Aryl Hydrocarbon Hydroxylases;Cytochrome P-450 Enzyme System
10852634;Dose-Response Relationship, Drug;Drug Interactions
10872652;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Food-Drug Interactions
10878206
10893655;Consumer Product Safety;Biological Availability
10930711;Phytotherapy
10945313;Time Factors;Food-Drug Interactions;Half-Life;Posture
10968409;Drug Synergism
11002387;Drug Contamination
11009051;Dose-Response Relationship, Drug;Psychomotor Performance;Half-Life;Biological Availability
11049012;Food-Drug Interactions;Half-Life
11061578;Mixed Function Oxygenases;Time Factors;Cytochrome P-450 CYP3A;Food-Drug Interactions;Cytochrome P-450 Enzyme System
11069440;Stereoisomerism;Food-Drug Interactions
11073292;Drug Interactions
11079273;Drug Interactions
11103749;Mixed Function Oxygenases;Drug Interactions;Cytochrome P-450 CYP3A;Half-Life
11108077;Drug Synergism;Hand
11117974;United States;United States Food and Drug Administration
11144706;Drug Interactions;Herb-Drug Interactions
11161079
11161541
11180019;Mixed Function Oxygenases;Drug Interactions;Duodenum;Intestine, Small;Cytochrome P-450 CYP3A;Enzyme Induction;Biological Availability;ATP-Binding Cassette, Sub-Family B, Member 1;Cytochrome P-450 Enzyme System
11180020;Drug Interactions
11180034;Caco-2 Cells;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Food-Drug Interactions;Biological Availability;Enzyme Activation;Cytochrome P-450 Enzyme System;DNA, Complementary
11185412;Food-Drug Interactions;Biological Availability
11194535;Diet Records
11203429;Anesthesia, General
11206893;Drug Interactions;Phytotherapy
11214770;Intestines;Stereoisomerism;Biological Availability
11214778;Stereoisomerism;Biotransformation;Food-Drug Interactions
11231102;Caco-2 Cells;Stereoisomerism;Food-Drug Interactions;Biological Availability;ATP-Binding Cassette, Sub-Family B, Member 1;Propanolamines
11257244;Premenopause
11269572;Biological Availability
11276296;MEDLINE;Drug Interactions;Phytotherapy;Safety
11310527;Drug Interactions
11322025;Food-Drug Interactions
11327742;Time Factors
11347624;HIV-1;Drug Interactions
11352440;Aza Compounds;Half-Life;Biological Availability
11356998;Databases, Factual
11361052;Dose-Response Relationship, Drug;Catecholamines;Acetamides
11365266;United States;Phytotherapy
11376916;Dose-Response Relationship, Drug;Psychomotor Performance;Attention;Automobile Driving;Postural Balance
11410431;Drug Antagonism
11426073;Drug Interactions;Food-Drug Interactions;Depression;Cytochrome P-450 Enzyme System
11454132;Sweden;Drug Interactions
11474706;Drug Interactions;Self Medication;Pain Management;Depression;Anxiety
11477318;Half-Life;Biological Availability
11481175;Drug Interactions;Magnoliopsida;Phytotherapy
11501187;Mixed Function Oxygenases;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP3A;Aryl Hydrocarbon Hydroxylases;Microsomes, Liver;Cytochrome P-450 Enzyme System
11524501;Drug Therapy, Combination
11554427;Drug Interactions;Blood Proteins;Biotransformation;Herb-Drug Interactions;Protein Binding;Medicine, Kampo;Microsomes, Liver;Cytochrome P-450 Enzyme System
11558205;Drug Interactions;Phytotherapy
11570073;Drug Interactions;Phytotherapy
11673746;Food-Drug Interactions;Genotype;ATP-Binding Cassette, Sub-Family B, Member 1;Polymorphism, Genetic
11675844;Cytochrome P-450 CYP2C9;Drug Interactions;Steroid 16-alpha-Hydroxylase;Aryl Hydrocarbon Hydroxylases;Steroid Hydroxylases;Cytochrome P-450 Enzyme System
11693229;Drug Interactions;Violence;Phytotherapy
11718495;Drug Interactions;Food-Drug Interactions
11728055;Drug Interactions;Drug Therapy, Combination
11728770;Drug Interactions;Leg
11740713;HIV-1;Enterocytes;Intestine, Small;Cytochrome P-450 Enzyme System
11745911;Food-Drug Interactions;Biological Availability;Acetamides
11753267;Drug Interactions;Biotransformation;Phytotherapy
11762562;Food-Drug Interactions
11763808;Seaweed;Food-Drug Interactions
11791889;Mixed Function Oxygenases;Drug Interactions;Cytochrome P-450 CYP3A;Food-Drug Interactions;Cytochrome P-450 Enzyme System
11797495;Drug Interactions;Sulfones;Lactones
11823753;Organic Anion Transporters;Food-Drug Interactions;Membrane Transport Proteins;Symporters;Biological Availability;ATP Binding Cassette Transporter, Sub-Family B;HeLa Cells;Organic Anion Transporters, Sodium-Dependent;Carrier Proteins
11823754;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Biotransformation;Food-Drug Interactions;Biological Availability;Sulfones;Cytochrome P-450 Enzyme System;Quality Control
11871046;Drug Interactions;Graft Rejection;ATP-Binding Cassette, Sub-Family B, Member 1;Cytochrome P-450 Enzyme System
11906584
11936572;Food-Drug Interactions;Therapeutic Equivalency
11953006;Drug Interactions;Depression;Phytotherapy;Drug Therapy, Combination
11956673;Mixed Function Oxygenases;Cytochrome P-450 CYP3A;Stereoisomerism;Food-Drug Interactions;Cytochrome P-450 CYP1A2;Cytochrome P-450 Enzyme System;Smoking
11959616;Food-Drug Interactions
11966676;Food-Drug Interactions;Biological Availability
12014354;Food-Drug Interactions
12040751;Food-Drug Interactions
12087344;Dose-Response Relationship, Drug;ATP-Binding Cassette, Sub-Family B, Member 1
12187697
12362932;Cytochrome P-450 CYP3A;Food-Drug Interactions;Cytochrome P-450 Enzyme System
12391711;Complementary Therapies;Quality of Life;Phytotherapy
12393786;Drug Interactions;Phytotherapy;Self Care
12394419;Dose-Response Relationship, Drug;Psychomotor Performance;Affect
12404692;Psychomotor Performance;Drug Interactions
12451428;Time Factors;Food-Drug Interactions;Biological Availability
12452752;Food-Drug Interactions
12463728;Time Factors;Food-Drug Interactions;Postprandial Period;Half-Life
12472986;Drug Interactions;Biological Availability
12482227;Drug Interactions
12495014;Escherichia coli;Fluorescent Dyes;Hydrogen-Ion Concentration
12503845;Psychiatric Status Rating Scales;Drug Interactions
12520633;Food-Drug Interactions;Therapeutic Equivalency
12545142;Intestinal Mucosa;Genes, MDR;Cytochrome P-450 CYP3A;Gene Expression Regulation;Enzyme Induction;Oxidoreductases, N-Demethylating;Aryl Hydrocarbon Hydroxylases
12554137;Indicators and Reagents
12580002;Drug Interactions;Chemistry, Clinical
12580992
12580993;Drug Interactions
12589390;Dose-Response Relationship, Drug;Psychomotor Performance;Sleep;Memory
12618710;Drug Interactions;Leg
12621384;Drug Interactions
12636154;Caco-2 Cells;Biological Transport
12649774;Drug Interactions;Drug Therapy, Combination
12672771;Physical Endurance;Sports
12677367;Drug Interactions
12680887;Psychomotor Performance;Time Factors;Food-Drug Interactions;Thinking
12695337;Drug Interactions;Time Factors;Cytochrome P-450 CYP3A;Half-Life;Cytochrome P-450 CYP2D6;Cytochrome P-450 Enzyme System
12757117;United States;United States Food and Drug Administration
12773074;Drug Interactions;Phytotherapy
12782911;Phytotherapy;Medicine, Kampo
12811362;Drug Interactions;Cytochrome P-450 CYP3A;Biotransformation;Food-Drug Interactions;Half-Life
12818420;Drug Interactions
12825970;Drug Interactions;Contraindications;Patient Education as Topic
12845387;Drug Interactions;Half-Life
12891227;Cytochrome P-450 CYP3A;Isoenzymes;Biotransformation;Half-Life;Cytochrome P-450 CYP2D6;Cytochrome P-450 Enzyme System
12906366;Cytochrome P-450 CYP1A2
12908854;Drug Interactions;Sex Factors
12915954;Drug Interactions;Time Factors;Half-Life;Cytochrome P-450 CYP1A2
12921244;Intestines;Genes, MDR;Food-Drug Interactions;Biological Availability;Genotype;ATP-Binding Cassette, Sub-Family B, Member 1
12940502;Cues;Dose-Response Relationship, Drug;Mental Processes;Behavior Control
12942422;Drug Interactions
12959294;Dose-Response Relationship, Drug;Cytochrome P-450 CYP3A
12971031;Food-Drug Interactions;Therapeutic Equivalency
13309332
13358299;Oximes;Hydroxylamines
13359661;Amphetamines
13811223
13855374
14088308
14100187;Toxicology
14132623;Toxicology;Oxidoreductases
14172385;Toxicology;Oxidoreductases
14214493;United States;Drug Industry;Legislation, Medical;United States Food and Drug Administration
14254960;Toxicology;Drug Therapy;Pharmacology
14280527;Toxicology;Drug Therapy;Anxiety
14498173;Gastrointestinal Tract
14567065;Blood Vessels;Dose-Response Relationship, Drug;Muscle, Smooth, Vascular;Angiotensin I;Anesthesia;Isometric Contraction;Muscle Relaxation;Endothelium, Vascular;Aorta, Thoracic
14595580;Dose-Response Relationship, Drug;Drug Interactions;Medicine, Chinese Traditional;Phytotherapy
14612100;Iran
14616409;Time Factors;Food-Drug Interactions;Biological Availability
14616429;Homozygote;Heterozygote;Cytochrome P-450 CYP1A2
14629295;Graft Rejection;Phytotherapy;Herbal Medicine;Kidney
14653226;Dose-Response Relationship, Drug;Time Factors;Food-Drug Interactions;Drug Tolerance;Postprandial Period;Therapeutic Equivalency
14663456;Dose-Response Relationship, Drug;Drug Interactions;Cytochrome P-450 CYP3A;Half-Life;Cytochrome P-450 CYP2D6;Cytochrome P-450 Enzyme System
14684645;Food-Drug Interactions;Pericardium
14713367;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP1A2;Enzyme Activation;Oxidoreductases, N-Demethylating;Aryl Hydrocarbon Hydroxylases;Xanthine Oxidase
14717783;Body Composition;Dose-Response Relationship, Drug
14725610;C-Reactive Protein;Hospitalization
14742762;Drug Interactions
14749695;Herb-Drug Interactions;Phytotherapy;Cytochrome P-450 Enzyme System
14765835;Food-Drug Interactions
14981197;Inactivation, Metabolic;Cytochrome P-450 CYP3A
15001969;Food-Drug Interactions;Receptors, Adrenergic, beta;Biological Availability
15001970;Mixed Function Oxygenases;Drug Interactions;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP3A;Sulfoxides;Aryl Hydrocarbon Hydroxylases;Cytochrome P-450 Enzyme System
15025743;Drug Therapy, Combination;Heptanoic Acids
15025748;Arylamine N-Acetyltransferase;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2D6;Xanthine Oxidase;Cytochrome P-450 Enzyme System
15060505;Dose-Response Relationship, Drug;Drug Interactions;Biological Availability;Cardiovascular System
15060508;Dose-Response Relationship, Drug;Drug Interactions;Jejunum;Half-Life;Biological Availability;Phytotherapy
15089812;Herb-Drug Interactions
15098799;Food-Drug Interactions;Biological Availability
15121490;Food-Drug Interactions
15151167;Food-Drug Interactions
15169710;Drug Interactions;Cyclohexanols;Phytotherapy;Drug Therapy, Combination
15176651;Herb-Drug Interactions;Half-Life
15179409;Drug Interactions;Chemistry, Pharmaceutical
15186565;Drug Interactions;Attitude to Health;Phytotherapy
15206993;Food-Drug Interactions
15223879;Mycobacterium tuberculosis;Drug Therapy, Combination
15229464;Cytochrome P-450 CYP3A;Stereoisomerism;Cytochrome P-450 Enzyme System
15231565;Dose-Response Relationship, Drug;Osteocalcin;Drug Antagonism;Prothrombin;Biological Availability
15238367;Drug Interactions;Phytotherapy
15292490;Drug Interactions;Methyl Ethers
15307118;Drug Interactions;Drug Resistance
15329598;Pupil;Intestines;Drug Interactions;Cytochrome P-450 CYP3A;Food-Drug Interactions;Half-Life;Oxidoreductases, N-Demethylating;Aryl Hydrocarbon Hydroxylases
15344253;Phytotherapy
15372129;Drug Interactions;Time Factors;Cytochrome P-450 Enzyme System
15449760;Drug Interactions;Phytotherapy
15470332;Drug Interactions;Phytotherapy;Terpenes
15506876;Time Factors;Cognition;Affect
15521566;Phytotherapy
15521893;Acetamides
15536458;Phenotype;Drug Interactions;Isoenzymes;Kinetics;Cytochrome P-450 Enzyme System
15581264;Drug Interactions
15592321
15592332;Biotransformation;Food-Drug Interactions;Biological Availability
15608563;Mixed Function Oxygenases;Pharmacogenetics;Time Factors;Cytochrome P-450 CYP2C19;Herb-Drug Interactions;Aryl Hydrocarbon Hydroxylases
15635366;United States;Food-Drug Interactions;Depression;Nutrition Policy
15655860;Herb-Drug Interactions
15673597;Cytochrome P-450 CYP3A;Food-Drug Interactions;Oxidoreductases, N-Demethylating;Aryl Hydrocarbon Hydroxylases;Microsomes, Liver
15735611;Organic Anion Transporters;Peptides;Food-Drug Interactions;Biological Availability
15735617;Canada;Time Factors;Sulfonamides
15801937;Herb-Drug Interactions;Protein Binding
15856409;Drug Interactions;Phytotherapy
15886802;Drug Interactions;Time Factors
15900287;Phenotype;Time Factors;Herb-Drug Interactions;Aryl Hydrocarbon Hydroxylases
15900292;Up-Regulation;Medicine, East Asian Traditional;Self Administration;Carcinogens, Environmental;Time Factors;Cytochrome P-450 CYP1A2;Forecasting;New Caledonia
15901751;Mixed Function Oxygenases;Cytochrome P-450 CYP2C19;Half-Life;Genotype;Aryl Hydrocarbon Hydroxylases
15903127;Duodenum;Genes, MDR;Food-Drug Interactions;RNA, Messenger;ATP-Binding Cassette, Sub-Family B, Member 1;Propanolamines
15983823;Food-Drug Interactions;Half-Life;Biological Availability
16062162;Adrenal Cortex Hormones;Herb-Drug Interactions;Herbal Medicine;Practice Guidelines as Topic
16100300;Lysine;Food-Drug Interactions;Biological Availability;Chemistry, Pharmaceutical;Therapeutic Equivalency
16116693;Pregnancy
16120075;Food-Drug Interactions;Thyroxine;Biological Availability
16122283;Absorption;Aza Compounds;Biological Availability
16133554;Drug Interactions;Medicine, Chinese Traditional
16203421
16221754;Haplotypes;Genes, MDR;Herb-Drug Interactions;Half-Life
16236039;Cytochrome P-450 CYP3A;Food-Drug Interactions;Heptanoic Acids;Cytochrome P-450 Enzyme System
16261361;Drug Interactions;Cytochrome P-450 CYP1A2
16305592;Food-Drug Interactions
16388930;Tissue Distribution;Extracellular Fluid;Acetamides;Muscle, Skeletal;Adipose Tissue
16412477;Intestines;Organic Anion Transporters;Food-Drug Interactions;Biological Availability;Organic Anion Transporters, Sodium-Independent;RNA, Messenger;Carrier Proteins;Hydrogen-Ion Concentration
16413247;Dose-Response Relationship, Drug;Algorithms;Drug Interactions;Food-Drug Interactions;Half-Life;Microsomes, Liver
16416305;Cytochrome P-450 CYP2C9;Dose-Response Relationship, Drug;Time Factors;Cytochrome P-450 CYP3A;Food-Drug Interactions;Half-Life;Aryl Hydrocarbon Hydroxylases;Cytochrome P-450 Enzyme System
16428919;Cytochrome P-450 CYP2C9;Drug Synergism;Herb-Drug Interactions;Aryl Hydrocarbon Hydroxylases;Microsomes, Liver
16484565;Drug Interactions;Safety
16541194;Drug Interactions;Intestine, Small;Cytochrome P-450 CYP3A;Biological Availability;Gastric Emptying;Cytochrome P-450 Enzyme System
16636327;Herb-Drug Interactions
16704760;Drug Interactions
16772772;Drug Synergism;Food-Drug Interactions
16923466;Creatine Kinase;Sulfonamides;Fluorobenzenes
16941417
17016323
17018502;Pregnancy;Gestational Age
17062300;Analgesia
17079360;Drug Interactions;Cytochrome P-450 CYP3A;Herb-Drug Interactions
17089110;Environmental Pollutants;Sex Factors;Genotype;Cytochrome P-450 CYP1A2;Smoking
17546822
17641611;Lower Extremity
18226589;Automation;Blood Proteins
20238900;Prothrombin;Blood
20301621
21010059;Prothrombin;Retinoids;Blood
21090491
22282124
25032445
8347123;Oximes;Biotransformation;Hydroxylamines;Nitriles;Aldehyde Dehydrogenase;Microsomes, Liver;Acetaldehyde;Cytochrome P-450 Enzyme System
12098842;Chemistry, Pharmaceutical
14255341;Toxicology;Alcohols
3677487
